curasan AG Signs Sales Agreement with Stryker S.A.
curasan AG has signed an agreement with Stryker S.A., Montreux, Switzerland, to sell and market bone replacement and regeneration materials for different orthopedic indications
Kleinostheim, Germany, February 11, 2011 --(PR.com)-- curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has signed an agreement with Stryker S.A., Montreux, Switzerland, to sell and market bone replacement and regeneration materials for different orthopedic indications.
Starting summer 2011, Stryker anticipates launching the products in selected European countries to be potentially followed by further target markets.
"Partnering with Stryker, a powerful global leader with experience in biologicals and biomaterials, opens up the highest-volume market segment for us, namely, orthopedics," stated curasan's CEO, Hans Dieter Rössler.
David Halliday, VP Spine, Biotech CMF with responsibility for these product lines across Europe similarly expressed his satisfaction with the new partnership: “Once Stryker Europe decided to commit to focusing its sales efforts on the high-growth biomaterials market, the joint venture with curasan was an excellent strategic match."
The two corporations are planning a long-term collaboration and the possible inclusion of future pipeline products from curasan AG in the agreement.
About curasan:
Exchange listed curasan AG (ISIN: DE 000 549 453 8) is one of the leading firms in the field of regenerative medicine especially in bone and tissue regeneration. In addition to the synthetic Cerasorb® bone substitution and regeneration material, the company has developed a future-oriented product pipeline, which will be ready for market rollout within the next few years via well-positioned contractual partners in various market segments.
www.curasan.com
About Stryker:
Stryker S.A. is the European Division of Stryker Corporation (NYSE:SYK), one of the world’s leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The company provides innovative orthopaedic implants as well as state-of-the-art medical and surgical equipment to help people lead more active and more satisfying lives. For more information about Stryker, please visit www.stryker.com.
###
Starting summer 2011, Stryker anticipates launching the products in selected European countries to be potentially followed by further target markets.
"Partnering with Stryker, a powerful global leader with experience in biologicals and biomaterials, opens up the highest-volume market segment for us, namely, orthopedics," stated curasan's CEO, Hans Dieter Rössler.
David Halliday, VP Spine, Biotech CMF with responsibility for these product lines across Europe similarly expressed his satisfaction with the new partnership: “Once Stryker Europe decided to commit to focusing its sales efforts on the high-growth biomaterials market, the joint venture with curasan was an excellent strategic match."
The two corporations are planning a long-term collaboration and the possible inclusion of future pipeline products from curasan AG in the agreement.
About curasan:
Exchange listed curasan AG (ISIN: DE 000 549 453 8) is one of the leading firms in the field of regenerative medicine especially in bone and tissue regeneration. In addition to the synthetic Cerasorb® bone substitution and regeneration material, the company has developed a future-oriented product pipeline, which will be ready for market rollout within the next few years via well-positioned contractual partners in various market segments.
www.curasan.com
About Stryker:
Stryker S.A. is the European Division of Stryker Corporation (NYSE:SYK), one of the world’s leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The company provides innovative orthopaedic implants as well as state-of-the-art medical and surgical equipment to help people lead more active and more satisfying lives. For more information about Stryker, please visit www.stryker.com.
###
Contact
curasan AG
Andrea Weidner
+49 (0)6027 40 900-51
www.curasan.de
Andrea Weidner
+49 (0)6027 40 900-51
www.curasan.de
Contact
Categories